Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.

Chest - 1 Aug 2014

Wallace Richard J, Brown-Elliott Barbara A, McNulty Steven, Philley Julie V, Killingley Jessica, Wilson Rebecca W, York Deanna S, Shepherd Sara, Griffith David E

Abstract excerpt

BACKGROUND: There is no large study validating the appropriateness of current treatment guidelines for Mycobacterium avium complex (MAC) lung disease. This is a retrospective single-center review evaluating the efficacy of macrolide/azalide-containing regimens for nodular/bronchiectatic (NB) MAC lung disease. METHODS: Patients were treated according to contemporary guidelines with evaluation of microbiologic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Azithromycin
Share to Bronchiectasis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Clarithromycin

Share to Lung Diseases

Share to Macrolides

Share to Mycobacterium avium Complex

Share to Mycobacterium avium-intracellulare Infection

Share to Sputum

Source

Open in PubMed Open full text

Identifiers

PMID: 24457542
DOI: 10.1378/chest.13-2538
PMCID: PMC4694082

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.PMID 24457542Read ↗

Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.Semantic proximity Read ↗

Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype.Semantic proximity Read ↗

Understanding recurrence in Mycobacterium avium complex pulmonary disease: genotypic strategies to support clinical decision-making.Semantic proximity Read ↗

Comparison of Clinical Features, Virulence, and Relapse among <i>Mycobacterium avium</i> Complex SpeciesSemantic proximity Read ↗

Treatment outcomes of macrolide-susceptible Mycobacterium abscessus lung disease.Semantic proximity Read ↗

Two Cases Report of Successful Treatment of Refractory Mac Pulmonary Disease in Two Different Elderly Patients Using a Regimen Using a Drug with an Innovative Drug Delivery System, Liposomal Amikacin (ALIS), at Half the Standard DoseSemantic proximity Read ↗

Spontaneous sputum conversion and reversion in Mycobacterium abscessus complex lung diseaseSemantic proximity Read ↗

Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis.Semantic proximity Read ↗

[Pulmonary MAC disease and the mycobacterial genotyping].Semantic proximity Read ↗

Recurrent tuberculosis in the United States and Canada: relapse or reinfection?Semantic proximity Read ↗

Rapid Molecular Detection of Inducible Macrolide Resistance in Mycobacterium chelonae and M. abscessus Strains: a Replacement for 14-Day Susceptibility Testing?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.